This Thyrogen market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.
The growth observed during the historic period can be credited to factors such as greater convenience, reduced healthcare costs, the adoption of telemedicine, a rise in breast cancer therapeutics, the increased use of Thyrogen, and a growing demand for thyroid cancer treatments.
The forecast period, growth is expected to be driven by the rising incidence of thyroid cancer, a greater focus on patient-centered healthcare, increased awareness and diagnosis of thyroid disorders, the growing prevalence of anaplastic thyroid cancer, and enhanced education and awareness. Key trends during this period include advancements in diagnostic technologies, innovations in treatment methods, new product launches, the development of innovative oncology drugs, and progress in biotechnology.
The increasing incidence of thyroid cancer is expected to drive the growth of the thyrogen market. Thyroid cancer originates in the thyroid gland and often presents as a lump or nodule in the neck. The rise in thyroid cancer cases is largely due to better detection through advanced imaging and biopsy techniques, as well as factors like radiation exposure and environmental changes. Thyrogen is used in thyroid cancer treatment to stimulate the thyroid gland, which aids in the detection of residual cancer and enhances the effectiveness of radioactive iodine therapy. For example, in January 2024, the American Cancer Society projected approximately 44,020 new cases of thyroid cancer in the U.S., up from 43,720 in 2023, including 12,500 in men and 31,520 in women. The anticipated increase in thyroid cancer cases is driving the growth of the thyrogen market.
The rising focus on personalized medicine is expected to significantly propel the growth of the thyrogen market. Personalized medicine tailors healthcare treatments based on individual genetic, lifestyle, and environmental factors, which leads to more precise healthcare outcomes, improved patient care, and reduced adverse effects. Thyrogen is increasingly being utilized in precision medicine, particularly for differentiated thyroid cancer, where it provides targeted diagnostic and therapeutic interventions, especially in patients with radioiodine-refractory disease. Thyrogen works by engaging thyroid-stimulating hormone receptors, offering a personalized treatment approach. For example, in February 2024, a report by the Personalized Medicine Coalition highlighted that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved treatments included seven cancer drugs, reflecting the growing application of personalized medicine in oncology. The increasing focus on personalized treatments, including the use of Thyrogen for targeted interventions in thyroid cancer, is driving the growth of the thyrogen market.
A key trend in the thyrogen market focuses on innovative applications, such as its use as a theranostic tool for diagnosing and treating differentiated thyroid cancer. This dual-purpose tool combines both diagnostic imaging and therapeutic applications, particularly for patients with radioiodine-refractory disease, by targeting thyroid-stimulating hormone receptors. For example, in June 2024, the Society of Nuclear Medicine and Molecular Imaging published research in the Journal of Nuclear Medicine, exploring the use of Thyrogen as a radiopharmaceutical for diagnosing and treating radioiodine-refractory differentiated thyroid cancer (DTC). This innovation reflects the shift towards precision medicine, where treatments and diagnostic methods are tailored to specific patient needs. Ongoing investment in research and innovation also supports the use of recombinant TSH in emerging clinical scenarios, further driving its adoption in the treatment of thyroid cancer.
Major players operating in the thyrogen market are Sanofi S.A.
North America was the largest region in the thyrogen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in thyrogen report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the thyrogen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Thyrogen (thyrotropin alfa) is a synthetic version of thyroid-stimulating hormone, utilized to detect thyroid cancer remnants in patients who have undergone thyroidectomy. It encourages the thyroid gland to absorb radioactive iodine, enabling diagnostic imaging and treatment, all without requiring thyroid hormone withdrawal.
Primary forms of thyrogen are vail and pre-filled. Vail Thyrogen refers to the distribution or usage of thyrotropin alfa by Genzyme in a specific setting, like a medical facility or practice in Vail. It includes product types such as thyrogen powder and injection, which are employed for diagnostic and therapeutic purposes. The end users of these products include hospitals, diagnostic centers, specialty clinics, and other healthcare providers.
The thyrogen market research report is one of a series of new reports that provides thyrogen market statistics, including thyrogen industry global market size, regional shares, competitors with a thyrogen market share, detailed thyrogen market segments, market trends and opportunities, and any further data you may need to thrive in the thyrogen industry. This thyrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thyrogen market consists of sales of products including, levothyroxine, radioactive iodine (I-131), proleukin, and Lugol’s iodine solution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth observed during the historic period can be credited to factors such as greater convenience, reduced healthcare costs, the adoption of telemedicine, a rise in breast cancer therapeutics, the increased use of Thyrogen, and a growing demand for thyroid cancer treatments.
The forecast period, growth is expected to be driven by the rising incidence of thyroid cancer, a greater focus on patient-centered healthcare, increased awareness and diagnosis of thyroid disorders, the growing prevalence of anaplastic thyroid cancer, and enhanced education and awareness. Key trends during this period include advancements in diagnostic technologies, innovations in treatment methods, new product launches, the development of innovative oncology drugs, and progress in biotechnology.
The increasing incidence of thyroid cancer is expected to drive the growth of the thyrogen market. Thyroid cancer originates in the thyroid gland and often presents as a lump or nodule in the neck. The rise in thyroid cancer cases is largely due to better detection through advanced imaging and biopsy techniques, as well as factors like radiation exposure and environmental changes. Thyrogen is used in thyroid cancer treatment to stimulate the thyroid gland, which aids in the detection of residual cancer and enhances the effectiveness of radioactive iodine therapy. For example, in January 2024, the American Cancer Society projected approximately 44,020 new cases of thyroid cancer in the U.S., up from 43,720 in 2023, including 12,500 in men and 31,520 in women. The anticipated increase in thyroid cancer cases is driving the growth of the thyrogen market.
The rising focus on personalized medicine is expected to significantly propel the growth of the thyrogen market. Personalized medicine tailors healthcare treatments based on individual genetic, lifestyle, and environmental factors, which leads to more precise healthcare outcomes, improved patient care, and reduced adverse effects. Thyrogen is increasingly being utilized in precision medicine, particularly for differentiated thyroid cancer, where it provides targeted diagnostic and therapeutic interventions, especially in patients with radioiodine-refractory disease. Thyrogen works by engaging thyroid-stimulating hormone receptors, offering a personalized treatment approach. For example, in February 2024, a report by the Personalized Medicine Coalition highlighted that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved treatments included seven cancer drugs, reflecting the growing application of personalized medicine in oncology. The increasing focus on personalized treatments, including the use of Thyrogen for targeted interventions in thyroid cancer, is driving the growth of the thyrogen market.
A key trend in the thyrogen market focuses on innovative applications, such as its use as a theranostic tool for diagnosing and treating differentiated thyroid cancer. This dual-purpose tool combines both diagnostic imaging and therapeutic applications, particularly for patients with radioiodine-refractory disease, by targeting thyroid-stimulating hormone receptors. For example, in June 2024, the Society of Nuclear Medicine and Molecular Imaging published research in the Journal of Nuclear Medicine, exploring the use of Thyrogen as a radiopharmaceutical for diagnosing and treating radioiodine-refractory differentiated thyroid cancer (DTC). This innovation reflects the shift towards precision medicine, where treatments and diagnostic methods are tailored to specific patient needs. Ongoing investment in research and innovation also supports the use of recombinant TSH in emerging clinical scenarios, further driving its adoption in the treatment of thyroid cancer.
Major players operating in the thyrogen market are Sanofi S.A.
North America was the largest region in the thyrogen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in thyrogen report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the thyrogen market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Thyrogen (thyrotropin alfa) is a synthetic version of thyroid-stimulating hormone, utilized to detect thyroid cancer remnants in patients who have undergone thyroidectomy. It encourages the thyroid gland to absorb radioactive iodine, enabling diagnostic imaging and treatment, all without requiring thyroid hormone withdrawal.
Primary forms of thyrogen are vail and pre-filled. Vail Thyrogen refers to the distribution or usage of thyrotropin alfa by Genzyme in a specific setting, like a medical facility or practice in Vail. It includes product types such as thyrogen powder and injection, which are employed for diagnostic and therapeutic purposes. The end users of these products include hospitals, diagnostic centers, specialty clinics, and other healthcare providers.
The thyrogen market research report is one of a series of new reports that provides thyrogen market statistics, including thyrogen industry global market size, regional shares, competitors with a thyrogen market share, detailed thyrogen market segments, market trends and opportunities, and any further data you may need to thrive in the thyrogen industry. This thyrogen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thyrogen market consists of sales of products including, levothyroxine, radioactive iodine (I-131), proleukin, and Lugol’s iodine solution. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Thyrogen Market Characteristics4. Thyrogen Market Trends and Strategies5. Thyrogen Market - Macro Economic Scenario Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Thyrogen Market Pricing Analysis & Forecasts30. Global Thyrogen Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Thyrogen Market32. Recent Developments in the Thyrogen Market
3. Thyrogen Market Biologic Drug Characteristics
6. Global Thyrogen Growth Analysis and Strategic Analysis Framework
8. Thyrogen Market Segmentation
9. Global Thyrogen Market Epidemiology of Clinical Indications
10. Thyrogen Market Regional and Country Analysis
11. Asia-Pacific Thyrogen Market
12. China Thyrogen Market
13. India Thyrogen Market
14. Japan Thyrogen Market
15. Australia Thyrogen Market
16. South Korea Thyrogen Market
17. Western Europe Thyrogen Market
18. UK Thyrogen Market
19. Germany Thyrogen Market
20. France Thyrogen Market
21. Eastern Europe Thyrogen Market
22. North America Thyrogen Market
23. USA Thyrogen Market
24. Canada Thyrogen Market
25. South America Thyrogen Market
26. Middle East Thyrogen Market
27. Africa Thyrogen Market
28. Thyrogen Market Competitive Landscape and Company Profiles
29. Global Thyrogen Market Pipeline Analysis
33. Thyrogen Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Thyrogen Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on thyrogen market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for thyrogen? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyrogen market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Vail; Pre-Filled2) by Product Type: Thyrogen Powder; Thyrogen Injection
3) by Application: Diagnostic; Therapeutic
4) by End-User: Hospitals; Diagnostic Centers; Specialty Clinics; Other End-Users
Key Companies Mentioned: Sanofi S.a.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Sanofi S.A.
